Biomea Fusion reports blood sugar control with icovamenib in type 2 diabetes study EP News Bureau Oct 7, 2025 Mid-stage trial results show sustained blood sugar reduction and potential benefit for patients unresponsive to GLP-1 therapies
Eli Lilly shares results from QWINT trials on once-weekly insulin efsitora for type 2 diabetes EP News Bureau Jun 23, 2025 Efsitora met primary endpoints across three Phase 3 trials, showing comparable glucose control to daily basal insulin therapies
Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India EP News Bureau Jun 19, 2025 Through this agreement, Abbott will distribute MSD’s Januvia, Janumet, and Janumet XR across India to support diabetes management…
